Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club
(2010) Osteoporosis International : with other metabolic bone diseases — Vol. 21, n° 10, p. 1657-1680 (2010)
Files
pdfdocument.pdf
Open Access - Adobe PDF
- 377.38 KB
Details
- Authors
- Abstract
- Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect.
- Affiliations
Citations
Body, J.-J., Devogelaer, J.-P., Bergmann, P., Boonen, S., Boutsen, Y., Goemaere, S., Kaufman, J.-M., Rozenberg, S., & Reginster, J. (2010). Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporosis International : with other metabolic bone diseases, 21(10), 1657-1680. https://doi.org/10.1007/s00198-010-1223-4 (Original work published 2010)